North Star Asset Management Inc Pfizer Inc Transaction History

North Star Asset Management Inc

$2.13 Billion
Q3 2024

A detailed history of North Star Asset Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, North Star Asset Management Inc holds 79,502 shares of PFE stock, worth $2.1 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

79,502

Previous 85,592 7.12%

Holding current value

$2.1 Million

Previous $2.39 Million 3.93%

% of portfolio

0.11%

Previous 0.12%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $168,693 - $191,165	-6,090 Reduced 7.12%	79,502 $2.3 Million
Q2 2024 Aug 05, 2024	SELL	$25.26 - $29.6 $699,171 - $819,298	-27,679 Reduced 24.44%	85,592 $2.39 Million
Q1 2024 May 08, 2024	SELL	$25.89 - $29.73 $318,913 - $366,214	-12,318 Reduced 9.81%	113,271 $3.14 Million
Q4 2023 Feb 01, 2024	SELL	$26.13 - $33.94 $191,454 - $248,678	-7,327 Reduced 5.51%	125,589 $3.62 Million
Q3 2023 Oct 26, 2023	SELL	$32.09 - $37.51 $146,234 - $170,933	-4,557 Reduced 3.31%	132,916 $4.41 Million
Q2 2023 Aug 09, 2023	SELL	$36.12 - $41.79 $139,025 - $160,849	-3,849 Reduced 2.72%	137,473 $5.04 Million
Q1 2023 May 10, 2023	SELL	$39.39 - $51.28 $89,257 - $116,200	-2,266 Reduced 1.58%	141,322 $5.77 Million
Q4 2022 Mar 06, 2023	SELL	$41.75 - $54.5 $124,122 - $162,028	-2,973 Reduced 2.03%	143,588 $7.36 Million
Q3 2022 Nov 08, 2022	SELL	$43.76 - $53.42 $94,346 - $115,173	-2,156 Reduced 1.45%	146,561 $6.41 Million
Q2 2022 Jul 28, 2022	SELL	$46.53 - $55.17 $132,424 - $157,013	-2,846 Reduced 1.88%	148,717 $7.8 Million
Q1 2022 Apr 29, 2022	SELL	$45.75 - $56.69 $185,928 - $230,388	-4,064 Reduced 2.61%	151,563 $7.85 Million
Q4 2021 Feb 07, 2022	SELL	$41.32 - $61.25 $20,040 - $29,706	-485 Reduced 0.31%	155,627 $9.19 Million
Q3 2021 Oct 20, 2021	SELL	$39.25 - $50.42 $17,191 - $22,083	-438 Reduced 0.28%	156,112 $6.71 Million
Q2 2021 Jul 30, 2021	BUY	$35.91 - $40.68 $70,563 - $79,936	1,965 Added 1.27%	156,550 $6.13 Million
Q1 2021 Apr 29, 2021	SELL	$33.49 - $37.77 $459,013 - $517,675	-13,706 Reduced 8.14%	154,585 $5.6 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $466,404 - $593,073	-13,935 Reduced 7.65%	168,291 $6.2 Million
Q3 2020 Nov 02, 2020	BUY	$31.75 - $37.25 $55,626 - $65,262	1,752 Added 0.97%	182,226 $6.69 Million
Q2 2020 Jul 28, 2020	SELL	$30.12 - $36.54 $94,637 - $114,808	-3,142 Reduced 1.71%	180,474 $5.9 Million
Q1 2020 Apr 24, 2020	SELL	$27.03 - $38.62 $384,582 - $549,485	-14,228 Reduced 7.19%	183,616 $5.99 Million
Q4 2019 Feb 06, 2020	SELL	$32.92 - $37.36 $31,109 - $35,305	-945 Reduced 0.48%	197,844 $7.75 Million
Q3 2019 Oct 25, 2019	SELL	$32.49 - $42.13 $73,589 - $95,424	-2,265 Reduced 1.13%	198,789 $7.14 Million
Q2 2019 Aug 12, 2019	SELL	$36.98 - $41.52 $56,764 - $63,733	-1,535 Reduced 0.76%	201,054 $8.71 Million
Q1 2019 Apr 26, 2019	SELL	$37.5 - $41.2 $146,025 - $160,432	-3,894 Reduced 1.89%	202,589 $8.6 Million
Q4 2018 Jan 29, 2019	SELL	$38.47 - $43.86 $193,003 - $220,045	-5,017 Reduced 2.37%	206,483 $9.01 Million
Q3 2018 Oct 29, 2018	SELL	$34.47 - $41.81 $142,498 - $172,842	-4,134 Reduced 1.92%	211,500 $9.32 Million
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $2,605 - $2,777	-79 Reduced 0.04%	215,634 $7.82 Million
Q1 2018 Apr 27, 2018	SELL	$31.91 - $37.02 $98,123 - $113,836	-3,075 Reduced 1.41%	215,713 $7.66 Million
Q4 2017 Feb 01, 2018	SELL	$33.26 - $35.29 $584,577 - $620,257	-17,576 Reduced 7.44%	218,788 $7.92 Million
Q3 2017 Oct 25, 2017	SELL	$31.0 - $34.15 $328,817 - $362,229	-10,607 Reduced 4.29%	236,364 $8.44 Million
Q3 2017 Oct 25, 2017	BUY	$31.0 - $34.15 $114,421 - $126,047	3,691 Added 1.52%	246,971 $8.45 Million
Q2 2017 Aug 16, 2017	BUY	N/A	243,280	243,280 $8.17 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on North Star Asset Management Inc with notifications on news.

Account

North Star Asset Management Inc Pfizer Inc Transaction History